Series C - Terns Pharmaceuticals - Jan 5, 2021 Funding Round Profile - Cointime

Bitcoin $98,412.81 +0.67%
Ethereum $3,501.20 +3.87%
BNB $668.04 +0.23%
Optimism $2.33 +5.88%
Arbitrum $0.92 +7.71%
Solana $254.04 +0.82%
Polygon $0.60 +7.23%
Cosmos $8.68 -3.28%
Avalanche $45.82 +10.65%

Bitcoin $98,412.81 +0.67%
Ethereum $3,501.20 +3.87%
BNB $668.04 +0.23%
Optimism $2.33 +5.88%
Arbitrum $0.92 +7.71%
Solana $254.04 +0.82%
Polygon $0.60 +7.23%
Cosmos $8.68 -3.28%
Avalanche $45.82 +10.65%

Terns Pharmaceuticals

company

Funding Round

Series C

Money Raised

$ 87M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Deepfield	-	Yes	-	Detail
Eli Lilly	-	Yes	-	Detail
Lilly Asia Ventures	-	-	-	Detail
OrbiMed	-	-	-	Detail
Samara Capital	-	-	-	Detail
Suvretta Capital Management	-	-	-	Detail
Vivo Capital	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Oct 30, 2018	Series B	$ 80M	Decheng Capital,Lilly Asia Ventures,etc.	Detail
Apr 4, 2018	Series A	$ 30M	Lilly Asia Ventures	Detail